Addex Therapeutics Ltd. Quarterly Interest Expense in CHF from Q2 2021 to Q2 2023

Taxonomy & unit
ifrs-full: CHF
Summary
Addex Therapeutics Ltd. annual/quarterly Interest Expense history and growth rate from Q2 2021 to Q2 2023.
  • Addex Therapeutics Ltd. Interest Expense for the quarter ending June 30, 2023 was ₣93.000, a 98.8% decline year-over-year.
  • Addex Therapeutics Ltd. annual Interest Expense for 2023 was ₣1.64K, a 93.6% decline from 2022.
  • Addex Therapeutics Ltd. annual Interest Expense for 2022 was ₣25.9K, a 33.9% decline from 2021.
  • Addex Therapeutics Ltd. annual Interest Expense for 2021 was ₣39.1K, a 22.4% decline from 2020.
Interest Expense, Quarterly (CHF)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 93 -7.48K -98.8% Apr 1, 2023 Jun 30, 2023 6-K/A 2023-12-21
Q2 2022 7.57K -9.7K -56.2% Apr 1, 2022 Jun 30, 2022 6-K/A 2023-12-21
Q2 2021 17.3K Apr 1, 2021 Jun 30, 2021 6-K/A 2022-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.